Ignite Creation Date:
2024-05-06 @ 7:17 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02508467
Status:
COMPLETED
Last Update Posted:
2024-04-12
First Post:
2015-07-09
Brief Title:
A Phase 1 Study of Fisogatinib BLU-554 in Patients With Hepatocellular Carcinoma
Sponsor:
Organization:
Blueprint Medicines Corporation